Milagen Inc. Richmond, Calif. Technology: Antibiomix high throughput polyclonal antibody generation for all proteins in any organism Disease focus: Cancer, inflammatory and infectious diseases Clinical status: NA Founded: 1997 by Moncef Jendoubi Corporate partners: None...

Antibodies have been used as biochemical reagents for more than 50 years, but most of the attention for both reagent and therapeutic use has been on monoclonals. Milagen Inc. is using its expertise in rapidly...